Urology · Homewood, AL
NPI
1962467969
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3485 Independence Dr
Homewood, AL, 35209
Phone (205) 930-0920
Groups this clinician bills Medicare through
Medicare paid, 2024
$177K
17,365 services
Medicare patients, 2024
552
Average age 75
Drug cost, 2024
$735K
3,535 prescriptions
Company payments, 2025
$563
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paula J Rookis was code J0585 (injection, onabotulinumtoxina, 1 unit), 12,000 times for 60 patients. In total Paula J Rookis billed 17,365 services in 61 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 12,000 | 60 | $4.87 | $58K |
| 81003 Clinical Chemistry | Office | 719 | 464 | $2.18 | $1,564 |
| 99213 Office E&M - Established | Office | 356 | 280 | $53.81 | $19K |
| 87086 Bacterial Culture | Office | 243 | 166 | $7.88 | $1,916 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 221 | 47 | $45.32 | $10K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 184 | 31 | $44.71 | $8,227 |
| 99214 Office E&M - Established | Office | 169 | 142 | $84.07 | $14K |
| 51798 Ultrasound - Nonspecific | Office | 150 | 126 | $6.83 | $1,024 |
| 87088 Bacterial Culture | Office | 130 | 96 | $7.93 | $1,031 |
| 87186 General Laboratory | Office | 129 | 96 | $8.48 | $1,094 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 84 | 30 | $34.63 | $2,909 |
| 52287 Cystourethroscopy | Office | 84 | 60 | $260.54 | $22K |
| 99203 Office E&M - New | Office | 49 | 49 | $72.47 | $3,551 |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 47 | 19 | $33.86 | $1,591 |
| 96372 Injection Administration | Office | 46 | 28 | $7.65 | $352 |
By year: 2022 $221K for 16,394 services; 2023 $200K for 18,498 services; 2024 $177K for 17,365 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 719 | 464 | $2.18 | $1,564 |
| 87086 Bacterial Culture | 243 | 166 | $7.88 | $1,916 |
| 87088 Bacterial Culture | 130 | 96 | $7.93 | $1,031 |
| 87186 General Laboratory | 129 | 96 | $8.48 | $1,094 |
Medicare prescription drug claims, 2024
In 2024, the drug Paula J Rookis prescribed most often to Medicare patients was Estradiol, with 532 prescriptions and refills. In total Paula J Rookis wrote 3,535 Medicare prescriptions that cost $735K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 532 | 1,442 | 356 | $43K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 493 | 961 | 180 | $20K |
| Gemtesa Vibegron | 374 | 658 | 112 | $311K |
| Myrbetriq Mirabegron | 353 | 619 | 98 | $267K |
| Cephalexin Generic | 283 | 512 | 115 | $4,745 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 237 | 247 | 175 | $3,278 |
| Trimethoprim Generic | 147 | 285 | 58 | $11K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 133 | 159 | 100 | $536 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 109 | 263 | 37 | $3,860 |
| Cefuroxime Cefuroxime Axetil | 82 | 89 | 62 | $1,524 |
| Solifenacin Succinate Generic | 81 | 199 | 34 | $6,161 |
| Methenamine Hippurate Generic | 71 | 142 | 24 | $4,897 |
| Ciprofloxacin Hcl Generic | 63 | 68 | 44 | $284 |
| Clobetasol Propionate Generic | 52 | 52 | 34 | $1,890 |
| Tamsulosin Hcl Generic | 50 | 100 | 22 | $554 |
Brand drugs: - claims; generic drugs: 2,584 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paula J Rookis $563 ($563 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $314.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.